The role of neutrophil myeloperoxidase in models of lung tumor development

Cancers

Volumn 6, Issue 2, 2014, Pages 1111-1127

  Rymaszewski, Amy L ^a   Tate, Everett ^a,c   Yimbesalu, Joannes P ^a   Gelman, Andrew E ^b   Jarzembowski, Jason A ^a   Zhang, Hao ^a   Pritchard Jr , Kirkwood A ^a   Vikis, Haris G ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b WASHINGTON UNIVERSITY   (United States)

^c UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

KYC; Lung; Myeloperoxidase; Neutrophils; Tumor

Indexed keywords

CASPASE 3; MYELOPEROXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GRAFT; CANCER GROWTH; CANCER STAGING; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME MECHANISM; ENZYME MODIFICATION; FEMALE; LEWIS CARCINOMA; LUNG CARCINOGENESIS; MOUSE; NEUTROPHIL; NONHUMAN; TUMOR ASSOCIATED LEUKOCYTE; TUMOR PROMOTION; TUMOR VOLUME;

EID: 84901207748     PISSN: None     EISSN: 20726694     Source Type: Journal    
DOI: 10.3390/cancers6021111     Document Type: Article

References (71)

1. American Cancer Society. Cancer facts & figures 2012; Atlanta, GA., USA, 2012.
2. Collins, L.G.; Haines, C.; Perkel, R.; Enck, R.E. Lung cancer: Diagnosis and management. Am. Fam. Physician 2007, 75, 56-63.
3. Siegel, R.; Desantis, C.; Virgo, K.; Stein, K.; Mariotto, A.; Smith, T.; Cooper, D.; Gansler, T.; Lerro, C.; Fedewa, S. et al. Cancer treatment and survivorship statistics, 2012. CA Cancer J Clin 2012, 62, 220-241.
4. Surveillance, epidemiology and end results. Available online: http://seer.cancer.gov/ (accessed on 18 December 2013).
5. Eheman, C.; Henley, S.J.; Ballard-Barbash, R.; Jacobs, E.J.; Schymura, M.J.; Noone, A.M.; Pan, L.; Anderson, R.N.; Fulton, J.E.; Kohler, B.A. et al. Annual report to the nation on the status of cancer, 1975-2008, featuring cancers associated with excess weight and lack of sufficient physical activity. Cancer 2012, 118, 2338-2366.
6. Coussens, L.M.; Werb, Z. Inflammation and cancer. Nature 2002, 420, 860-867.
7. Balkwill, F.; Charles, K.A.; Mantovani, A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell 2005, 7, 211-217.
8. Grivennikov, S.I.; Greten, F.R.; Karin, M. Immunity, inflammation, and cancer. Cell 2010, 140, 883-899.
9. Grivennikov, S.I.; Karin, M. Inflammation and oncogenesis: A vicious connection. Curr. Opin. Genet. Dev. 2010, 20, 65-71.
10. Federico, A.; Morgillo, F.; Tuccillo, C.; Ciardiello, F.; Loguercio, C. Chronic inflammation and oxidative stress in human carcinogenesis. Int. J. Cancer 2007, 121, 2381-2386.
11. Bauer, A.K.; Rondini, E.A. Review paper: The role of inflammation in mouse pulmonary neoplasia. Vet. Pathol. 2009, 46, 369-390.
12. Witschi, H.R.; Morse, C.C. Enhancement of lung tumor formation in mice by dietary butylated hydroxytoluene: Dose-time relationships and cell kinetics. J. Natl. Cancer Inst. 1983, 71, 859-866.
13. Witschi, H.P. Enhancement of tumor formation in mouse lung by dietary butylated hydroxytoluene. Toxicology 1981, 21, 95-104.
14. Malkinson, A.M.; Koski, K.M.; Evans, W.A.; Festing, M.F. Butylated hydroxytoluene exposure is necessary to induce lung tumors in balb mice treated with 3-methylcholanthrene. Cancer Res. 1997, 57, 2832-2834.
15. Bauer, A.K.; Dwyer-Nield, L.D.; Keil, K.; Koski, K.; Malkinson, A.M. Butylated hydroxytoluene (bht) induction of pulmonary inflammation: A role in tumor promotion. Exp. Lung Res. 2001, 27, 197-216.
16. Bauer, A.K.; Dwyer-Nield, L.D.; Hankin, J.A.; Murphy, R.C.; Malkinson, A.M. The lung tumor promoter, butylated hydroxytoluene (bht), causes chronic inflammation in promotion-sensitive balb/cbyj mice but not in promotion-resistant cxb4 mice. Toxicology 2001, 169, 1-15.
17. Bauer, A.K.; Malkinson, A.M.; Kleeberger, S.R. Susceptibility to neoplastic and non-neoplastic pulmonary diseases in mice: Genetic similarities. Am. J. Physiol. Lung Cell. Mol. Physiol. 2004, 287, L685-L703.
18. Rondini, E.A.; Walters, D.M.; Bauer, A.K. Vanadium pentoxide induces pulmonary inflammation and tumor promotion in a strain-dependent manner. Part Fibre Toxicol. 2010, 7, 9.
19. Vikis, H.G.; Gelman, A.E.; Franklin, A.; Stein, L.; Rymaszewski, A.; Zhu, J.; Liu, P.; Tichelaar, J.W.; Krupnick, A.S.; You, M. Neutrophils are required for 3-methylcholanthrene-initiated, butylated hydroxytoluene-promoted lung carcinogenesis. Mol. Carcinog. 2012, 51, 993-1002.
20. Jamieson, T.; Clarke, M.; Steele, C.W.; Samuel, M.S.; Neumann, J.; Jung, A.; Huels, D.; Olson, M.F.; Das, S.; Nibbs, R.J. et al. Inhibition of cxcr2 profoundly suppresses inflammation-driven and spontaneous tumorigenesis. J. Clin. Invest. 2012, 122, 3127-3144.
21. Baniyash, M. Chronic inflammation, immunosuppression and cancer: New insights and outlook. Semin. Cancer Biol. 2006, 16, 80-88.
22. Brody, J.S.; Spira, A. State of the art. Chronic obstructive pulmonary disease, inflammation, and lung cancer. Proc. Am. Thorac. Soc. 2006, 3, 535-537.
23. Houghton, A.M.; Mouded, M.; Shapiro, S.D. Common origins of lung cancer and copd. Nat. Med. 2008, 14, 1023-1024.
24. Schwartz, A.G.; Ruckdeschel, J.C. Familial lung cancer: Genetic susceptibility and relationship to chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2006, 173, 16-22.
25. Di Stefano, A.; Capelli, A.; Lusuardi, M.; Balbo, P.; Vecchio, C.; Maestrelli, P.; Mapp, C.E.; Fabbri, L.M.; Donner, C.F.; Saetta, M. Severity of airflow limitation is associated with severity of airway inflammation in smokers. Am. J. Respir. Crit. Care Med. 1998, 158, 1277-1285.
26. Hanahan, D.; Weinberg, R.A. Hallmarks of cancer: The next generation. Cell 2011, 144, 646-674.
27. Coussens, L.M.; Werb, Z. Inflammatory cells and cancer: Think different! J. Exp. Med. 2001, 193, F23-F26.
28. Gregory, A.D.; McGarry Houghton, A. Tumor-associated neutrophils: New targets for cancer therapy. Cancer Res. 2011, 71, 2411-2416.
29. Houghton, A.M. The paradox of tumor-associated neutrophils: Fueling tumor growth with cytotoxic substances. Cell Cycle 2010, 9, 1732-1737.
30. Guthrie, G.J.; Charles, K.A.; Roxburgh, C.S.; Horgan, P.G.; McMillan, D.C.; Clarke, S.J. The systemic inflammation-based neutrophil-lymphocyte ratio: Experience in patients with cancer. Crit. Rev. Oncol. Hematol. 2013, 88, 218-230.
31. Bellocq, A.; Antoine, M.; Flahault, A.; Philippe, C.; Crestani, B.; Bernaudin, J.F.; Mayaud, C.; Milleron, B.; Baud, L.; Cadranel, J. Neutrophil alveolitis in bronchioloalveolar carcinoma: Induction by tumor-derived interleukin-8 and relation to clinical outcome. Am. J. Pathol. 1998, 152, 83-92.
32. Ilie, M.; Hofman, V.; Ortholan, C.; Bonnetaud, C.; Coelle, C.; Mouroux, J.; Hofman, P. Predictive clinical outcome of the intratumoral cd66b-positive neutrophil-to-cd8-positive t-cell ratio in patients with resectable nonsmall cell lung cancer. Cancer 2012, 118, 1726-1737.
33. Donskov, F. Immunomonitoring and prognostic relevance of neutrophils in clinical trials. Semin. Cancer Biol. 2013, 23, 200-207.
34. Faurschou, M.; Borregaard, N. Neutrophil granules and secretory vesicles in inflammation. Microbes Infect. 2003, 5, 1317-1327.
35. Nathan, C. Neutrophils and immunity: Challenges and opportunities. Nat. Rev. Immunol. 2006, 6, 173-182.
36. Winterbourn, C.C.; Kettle, A.J. Biomarkers of myeloperoxidase-derived hypochlorous acid. Free Radic. Biol. Med. 2000, 29, 403-409.
37. Hoy, A.; Leininger-Muller, B.; Kutter, D.; Siest, G.; Visvikis, S. Growing significance of myeloperoxidase in non-infectious diseases. Clin. Chem. Lab. Med. 2002, 40, 2-8.
38. Klebanoff, S.J. Myeloperoxidase: Friend and foe. J. Leukoc. Biol. 2005, 77, 598-625.
39. Malle, E.; Furtmuller, P.G.; Sattler, W.; Obinger, C. Myeloperoxidase: A target for new drug development? Br. J. Pharmacol. 2007, 152, 838-854.
40. Gomez-Mejiba, S.E.; Zhai, Z.; Gimenez, M.S.; Ashby, M.T.; Chilakapati, J.; Kitchin, K.; Mason, R.P.; Ramirez, D.C. Myeloperoxidase-induced genomic DNA-centered radicals. J. Biol. Chem. 2010, 285, 20062-20071.
41. Gungor, N.; Knaapen, A.M.; Munnia, A.; Peluso, M.; Haenen, G.R.; Chiu, R.K.; Godschalk, R.W.; van Schooten, F.J. Genotoxic effects of neutrophils and hypochlorous acid. Mutagenesis 2010, 25, 149-154.
42. Saed, G.M.; Ali-Fehmi, R.; Jiang, Z.L.; Fletcher, N.M.; Diamond, M.P.; Abu-Soud, H.M.; Munkarah, A.R. Myeloperoxidase serves as a redox switch that regulates apoptosis in epithelial ovarian cancer. Gynecol. Oncol. 2010, 116, 276-281.
43. Mika, D.; Guruvayoorappan, C. Myeloperoxidase: The yin and yang in tumour progression. J. Exp. Ther. Oncol. 2011, 93-100.
44. van der Veen, B.S.; de Winther, P.J.; Heeringa, P. Myeloperoxidase: Molecular mechanisms of action and their relevance to human health and disease. Antioxid. Redox Signal. 2009, 11, 2899-2937.
45. Knaapen, A.M.; Gungor, N.; Schins, R.P.; Borm, P.J.; Van Schooten, F.J. Neutrophils and respiratory tract DNA damage and mutagenesis: A review. Mutagenesis 2006, 21, 225-236.
46. Reuter, S.; Gupta, S.C.; Chaturvedi, M.M.; Aggarwal, B.B. Oxidative stress, inflammation, and cancer: How are they linked? Free Radic. Biol. Med. 2010, 49, 1603-1616.
47. Haegens, A.; Vernooy, J.H.; Heeringa, P.; Mossman, B.T.; Wouters, E.F. Myeloperoxidase modulates lung epithelial responses to pro-inflammatory agents. Eur. Respir. J. 2008, 31, 252-260.
48. Van Schooten, F.J.; Boots, A.W.; Knaapen, A.M.; Godschalk, R.W.; Maas, L.M.; Borm, P.J.; Drent, M.; Jacobs, J.A. Myeloperoxidase (mpo) -463G→A reduces mpo activity and DNA adduct levels in bronchoalveolar lavages of smokers. Cancer Epidemiol. Biomarkers Prev. 2004, 13, 828-833.
49. Larsson, S.; Nordenson, A.; Glader, P.; Yoshihara, S.; Linden, A.; Slinde, F. A gender difference in circulating neutrophils in malnourished patients with copd. Int. J. Chronic Obstruct. Pulmon. Dis. 2011, 6, 83-88.
50. Vaguliene, N.; Zemaitis, M.; Lavinskiene, S.; Miliauskas, S.; Sakalauskas, R. Local and systemic neutrophilic inflammation in patients with lung cancer and chronic obstructive pulmonary disease. BMC Immunol. 2013, 14, 36.
51. Zhang, H.; Jing, X.; Shi, Y.; Xu, H.; Du, J.; Guan, T.; Weihrauch, D.; Jones, D.W.; Wang, W.; Gourlay, D. et al. N-acetyl lysyltyrosylcysteine amide inhibits myeloperoxidase, a novel peptide based inhibitor. J. Lipid. Res. 2013, doi:10.1194/ jlr. M038273.
52. Zhang, H.; Xu, H.; Weihrauch, D.; Jones, D.W.; Jing, X.; Shi, Y.; Gourlay, D.; Oldham, K.T.; Hillery, C.A.; Pritchard, K.A., Jr. Inhibition of myeloperoxidase decreases vascular oxidative stress and increases vasodilatation in sickle cell disease mice. J. Lipid. Res. 2013, 54, 3009-3015.
53. Moghaddam, S.J.; Li, H.; Cho, S.N.; Dishop, M.K.; Wistuba, I.I.; Ji, L.; Kurie, J.M.; Dickey, B.F.; Demayo, F.J. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a k-ras-induced mouse model. Am. J. Respir. Cell Mol. Biol. 2009, 40, 443-453.
54. Melkamu, T.; Qian, X.; Upadhyaya, P.; O'Sullivan, M.G.; Kassie, F. Lipopolysaccharide enhances mouse lung tumorigenesis: A model for inflammation-driven lung cancer. Vet. Pathol. 2013, 50, 895-902.
55. Sethi, S.; Maloney, J.; Grove, L.; Wrona, C.; Berenson, C.S. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2006, 173, 991-998.
56. Haegens, A.; van der Vliet, A.; Butnor, K.J.; Heintz, N.; Taatjes, D.; Hemenway, D.; Vacek, P.; Freeman, B.A.; Hazen, S.L.; Brennan, M.L. et al. Asbestos-induced lung inflammation and epithelial cell proliferation are altered in myeloperoxidase-null mice. Cancer Res. 2005, 65, 9670-9677.
57. El Kebir, D.; Jozsef, L.; Pan, W.; Filep, J.G. Myeloperoxidase delays neutrophil apoptosis through cd11b/cd18 integrins and prolongs inflammation. Circ. Res. 2008, 103, 352-359.
58. Lefkowitz, D.L.; Mills, K.; Morgan, D.; Lefkowitz, S.S. Macrophage activation and immunomodulation by myeloperoxidase. Proc. Soc. Exp. Biol. Med. 1992, 199, 204-210.
59. Lefkowitz, D.L.; Mills, K.C.; Moguilevsky, N.; Bollen, A.; Vaz, A.; Lefkowitz, S.S. Regulation of macrophage function by human recombinant myeloperoxidase. Immunol. Let. 1993, 36, 43-49.
60. Johansson, M.W.; Patarroyo, M.; Oberg, F.; Siegbahn, A.; Nilsson, K. Myeloperoxidase mediates cell adhesion via the alpha m beta 2 integrin (mac-1, cd11b/cd18). J. Cell Sci. 1997, 110, 1133-1139.
61. Pertuska, J.M.; Moosebrook, D.R.; Jakab, G.J.; Trush, M.A. Myeloperoxidase-enhance d formation of -7,8-dihydroxy7,8-dihydrobenzoapyrene-DNA adducts in lung tissue in vitro: A role of pulmonary inflammation in the bioactivation of a procarcinogen. Carcinogenesis 1992, 13, 1075-1081.
62. Meyer, A.M.; Dwyer-Nield, L.D.; Hurteau, G.; Keith, R.L.; Ouyang, Y.; Freed, B.M.; Kisley, L.R.; Geraci, M.W.; Bonventre, J.V.; Nemenoff, R.A. et al. Attenuation of the pulmonary inflammatory response following butylated hydroxytoluene treatment of cytosolic phospholipase a2 null mice. Am. J. Physiol. Lung Cell Mol. Physiol. 2006, 290, L1260-1266.
63. Gong, L.; Cumpian, A.C.; da Silva Caetano, M.; Ochoa, C.E.; De la Garza, M.M.; Lapid, D.J.; Mirabolfathinejad, S.G.; Dickey, B.F.; Zhou, Q.; Moghaddam, S.J. Promoting effect of neutrophils on lung tumorigenesis is mediated by cxcr2 and neutrophil elastase. Mol. Cancer 2013, 12, 154.
64. Houghton, A.M.; Rzymkiewicz, D.M.; Ji, H.; Gregory, A.D.; Egea, E.E.; Metz, H.E.; Stolz, D.B.; Land, S.R.; Marconcini, L.A.; Kliment, C.R. et al. Neutrophil elastase-mediated degradation of irs-1 accelerates lung tumor growth. Nat. Med. 2010, 16, 219-223.
65. Yang, J.J.; Preston, G.A.; Pendergraft, W.F.; Segelmark, M.; Heeringa, P.; Hogan, S.L.; Jennette, J.C.; Falk, R.J. Internalization of proteinase 3 is concomitant with endothelial cell apoptosis and internalization of myeloperoxidase with generation of intracellular oxidants Am. J. Pathol. 2001, 158, 581-592.
66. Churg, A.; Marshall, C.V.; Sin, D.D.; Bolton, S.; Zhou, S.; Thain, K.; Cadogan, E.B.; Maltby, J.; Soars, M.G.; Mallinder, P.R. et al. Late intervention with a myeloperoxidase inhibitor stops progression of experimental chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 2012, 185, 34-43.
67. Lanza, F. Clinical manifestation of myeloperoxidase deficiency. J. Mol. Med. (Berl) 1998, 76, 676-681.
68. Nauseef, W.M. How human neutrophils kill and degrade microbes: An integrated view. Immunol. Rev. 2007, 219, 88-102.
69. Okazaki, M.; Krupnick, A.S.; Kornfeld, C.G.; Lai, J.M.; Ritter, J.H.; Richardson, S.B.; Huang, H.J.; Das, N.A.; Patterson, G.A.; Gelman, A.E. et al. A mouse model of orthotopic vascularized aerated lung transplantation. Am. J. Transplant 2007, 7, 1672-1679.
70. Corp, W.B. Worthington enzyme manual. Worthington Biochemical Corporation: Freehold, NJ, USA, 1972.
71. Bradley, P.P.; Priebat, D.A.; Christensen, R.D.; Rothstein, G. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 1982, 78, 206-209002E